Open AccessRituximab versus tocilizumab and B-cell status in TNF-alpha inadequate-responder rheumatoid arthritis patients: the R4-RA RCT
Author(s) -
Frances Humby,
Patrick Durez,
Maya H Buch,
Myles Lewis,
Stefano Bombardieri,
Christopher R. John,
Hasan Rizvi,
Louise Warren,
Joanna Peel,
Liliane FossatiJimack,
Rebecca Hands,
Giovanni Giorli,
Felice Rivellese,
Juan D. Cañete,
Peter C. Taylor,
Peter Sasieni,
João Eurico Fonseca,
Ernest Choy,
Costantino Pitzalis
Publication year - 2022
Publication title -
efficacy and mechanism evaluation
Language(s) - English
Resource type - Journals
eISSN - 2050-4373
pISSN - 2050-4365
DOI - 10.3310/gopl1729
Subject(s) - medicine , rituximab , tocilizumab , rheumatoid arthritis , cd20 , rheumatology , immunology , gastroenterology , lymphoma
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom